feed,title,long_url,short_url
InsiderMonkey,GIBO Holdings Limited (GIBO) Unveils SparkRWA to Merge IP Tokenization and Asset Verification,https://insidermonkey.com/blog/--1545275,
InsiderMonkey,Grindr Inc. (GRND)’s Right Now Feature goes Global,https://insidermonkey.com/blog/--1545093,
InsiderMonkey,"Actuate Therapeutics, Inc. (ACTU)’s Elraglusib Elraglusib Trial Hits Key Goals in Pancreatic Cancer",https://insidermonkey.com/blog/--1545338,
InsiderMonkey,Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial,https://insidermonkey.com/blog/--1545340,
InsiderMonkey,"Regeneron Pharmaceuticals, Inc. (REGN) Shares Plunge Despite Positive Phase 3 Itepekimab Results",https://insidermonkey.com/blog/--1545346,
InsiderMonkey,"Tempus AI, Inc. (TEM) Launches ‘Fuses’ to Power AI-Driven Precision Diagnostics",https://insidermonkey.com/blog/--1545348,
InsiderMonkey,"Gilead Sciences, Inc, (GILD)’s Trodelvy and Merck & Co., Inc, (MRK)’s Keytruda Cuts Breast Cancer Progression Risk by 35%",https://insidermonkey.com/blog/--1545353,
InsiderMonkey,"Guardant Health, Inc. (GH)’s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III Patients",https://insidermonkey.com/blog/--1545357,
InsiderMonkey,BeOne Medicines Ltd. (ONC)’s Combo Drug Shows Strong CLL Response,https://insidermonkey.com/blog/--1545359,
InsiderMonkey,"Xilio Therapeutics, Inc. (XLO) Reports 26% Response in Colon Cancer Drug Trial",https://insidermonkey.com/blog/--1545361,
InsiderMonkey,AbCellera Biologics Inc. (ABCL) Approved to Begin ABCL575 Trial for Atopic Dermatitis,https://insidermonkey.com/blog/--1545002,
InsiderMonkey,"Kymera Therapeutics, Inc. (KYMR) to Announce KT-621 Phase 1 Results on June 2, 2025",https://insidermonkey.com/blog/--1544988,
InsiderMonkey,"Perspective Therapeutics, Inc. (CATX) Reports Positive Results for NET Treatment Trial",https://insidermonkey.com/blog/--1544982,
